Disc Medicine

IRONNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.630 B

$68.49 -1.50%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$212.2M

Loss-making

Shares outstanding

38,392,844

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#82NewAmsterdam PharmaNAMS$2.70B
#83Nurix TherapeuticsNRIX$2.64B
#84Disc MedicineIRON$2.63B
#85Structure TherapeuticsGPCR$2.62B
#86HUTCHMED (China)HCM$2.53B

What if Disc Medicine were worth as much as…

Open the what-if tool →

Gold $30.3T

$788,533.77

Per share 11,513× higher

Bitcoin $1.72T

$44,794.90

Per share 654× higher

Nvidia $5.48T

$142,731.23

Per share 2,084× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Disc Medicine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.